SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN OBSESSIVE-COMPULSIVE DISORDER

摘要

Since we reviewed the selective serotonin reuptake inhibitor (SSRI) antidepressants two years ago two of them, fluoxetine (Prozac - Dista) and fluvoxamine (Faverin - Duphar), have also been licensed for the treatment of patients with obsessive-compulsive disorder. How do these and the other SSRIs available in the UK - paroxetine (Seroxat-SmithKline Beecham) and sertraline(Lustral-Invicta/Pfizer)-compare with clomipramine, a standard drug treatment for this disorder?